Clinical Trial Update: Pilot Comparative Bioavailability Study of 6Mercaptopurine (Delayed Release vs. Purinethol) in Crohns Disease Patients [Phase 1]

View source ↗

Summary

A Phase 1 pilot study compared the bioavailability of delayed-release 6-mercaptopurine with Purinethol in Crohn's disease patients and the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• 6-mercaptopurine (delayed-release) (6-mercaptopurine)
• Purinethol (6-mercaptopurine)

Snippet

Sponsor: Teva GTC | Conditions: Crohns Disease | Phase 1 | Status: COMPLETED